One longstanding enigma clarified by this study concerns why RHEB–GTP, the key growth factor-dependent activator of mTORC1, exhibits surprisingly low affinity for mTORC1 in solution. By incorporating physiological concentrations of lipidated RHEB–GTP and anchoring it to liposomal membranes alongside membrane-bound Ragulator and the RAG GTPase dimer, researchers recreated a near-native environment that sharply potentiated mTORC1 kinase activation. This reflects a profound impact of spatial organization: tethering RHEB to the membrane boosts its local concentration around mTORC1, facilitating interaction and activation in a way unattainable in solution. This finding underscores the critical importance of ‘reduction of dimensionality’—the confinement of diffusible molecules to two-dimensional membrane surfaces—which effectively increases the encounter rate between regulators and their targets.

Yet membrane tethering alone could not explain the full extent of mTORC1 activation. High-resolution cryo-EM revealed that both the mTOR kinase itself and the RAPTOR subunit establish direct physical contacts with the lysosomal membrane, prompting sweeping conformational rearrangements across the mTORC1 complex. These allosteric shifts span multiple domains separated by vast molecular distances exceeding 230 angstroms, from the HEAT repeats through the FAT domain to the kinase lobes. Such large-scale remodeling reorients critical kinase elements, fine-tuning the active site geometry to achieve maximal catalytic efficiency. This multi-domain membrane engagement emerges as a central theme in mTORC1 activation, highlighting the lysosomal membrane not merely as a localization platform but as an active allosteric modulator.

In a particularly intriguing extension, membrane shape dynamics appear to contribute meaningfully to mTORC1 regulation. Lysosomes, known to undergo marked tubulation and swelling during their functional cycles and stress responses, potentially influence kinase activation by altering the curvature and tension of the membrane interface. The study’s biochemical reconstitutions demonstrate that mTORC1 activation correlates with liposome shape, suggesting that the mechanical properties of membranes provide an additional regulatory axis modulating the signaling output. Such findings hint at a sophisticated integration of biophysical and biochemical signals in the spatial control of cell growth pathways.

From an evolutionary perspective, the distinctive membrane anchoring mode of mTOR diverges from other PIKK family kinases, which commonly respond to damage signals via localized rearrangements. However, the structural alignments between activated mTORC1 and relatives like ATM, ATR (MEC1), and DNA-PK reveal conserved rearrangements in the kinase active sites, situating mTOR within a broader family of stress-responsive enzymes while also highlighting its unique spatial regulation on membranes. This alignment of ATP binding sites across PIKKs reinforces the functional significance of the membrane-induced conformational transitions discovered.

Furthermore, an unexpected finding emerged with the identification of a second RAG–Ragulator binding site localized on the MLST8 subunit, a component shared between mTORC1 and mTORC2. Intriguingly, this site is sterically occluded in mTORC2 by SIN1, consistent with mTORC2’s lack of interaction with RAG GTPases. The new binding interface also overlaps with the docking site of the inhibitory protein PRAS40, an insulin-responsive antagonist of mTORC1. Although MLST8 is dispensable for mTORC1’s basal activity, the discovery raises compelling questions about how RAG–Ragulator might modulate inhibition by PRAS40 or influence lysosomal recruitment, suggesting additional layers of nuanced regulation.

The integration of nutrient and growth factor signaling on the lysosome emerges through a finely tuned four-step mechanism delineated by this work. Initially, the RAG–Ragulator complex tethers mTORC1 in proximity to the lysosomal membrane within approximately 10 nanometers, creating a spatial microenvironment conducive to subsequent interactions. Next, RHEB–GTP, itself membrane-anchored at variable distances from the membrane, captures mTORC1 within a target zone of roughly 1.5 to 4 nanometers, initiating the hallmark conformational changes indicative of kinase activation. Membrane docking is then driven initially by the RAPTOR ‘finger’ motif, which contacts the membrane in both intermediate and fully active states. Finally, the direct engagement of mTOR’s membrane-interacting site solidifies the fully active conformation, signifying maximal enzymatic output.

This comprehensive structural model reconciles how a transient and spatially restricted pool of RHEB localized on lysosomes can exert powerful control over mTORC1 activity amidst abundant competing cellular signals. By invoking both biochemical specificity and mechanical membrane interactions, it reveals how nutrient availability and growth factor cues converge physically and functionally on mTORC1. Notably, these findings also open new avenues investigating how membrane shape fluctuations and lipid composition dynamically regulate the growth machinery, with implications for understanding lysosomal physiology and pathologies marked by dysregulated mTOR signaling.

Although the current cryo-EM analyses represent major advances compared to previous membrane-free structures, the authors prudently acknowledge the possibility of further structural nuances emerging once atomistic resolution of mTORC1 on native lysosomal membranes in living cells becomes achievable. Such in situ structural elucidations will likely refine our understanding of the precise kinetics and thermodynamics underlying membrane engagement and enzymatic activation. Moreover, the study highlights the value of future biophysical assays—such as single-molecule Förster resonance energy transfer—to dissect the temporal coordination between conformational dynamics and catalytic rates.

An additional unresolved question pertains to how membrane interactions influence mTORC1’s phosphorylation of noncanonical substrates like TFEB, which depend on RAG–Ragulator but not RHEB. The complex interplay between multiple regulatory axes, including these discrete phosphorylation events, underscores the multifaceted nature of mTORC1 as a signaling hub. Further mechanistic insight into these distinct modalities promises to deepen our understanding of how cellular metabolic homeostasis is finely tuned in physiological and pathological states.

Collectively, this study elegantly elucidates the structural logic of mTORC1 activation on the lysosomal membrane, elevating our molecular understanding of a crucial signaling node that governs cell growth and metabolism. By integrating biochemical reconstitution, high-resolution cryo-EM, and mechanistic modeling, the work captures the spatial and dynamic intricacies that enable mTORC1 to serve as a central integrator of nutritional and growth factor signals. These revelations have profound implications, potentially informing targeted modulation of mTOR signaling in cancer, metabolic diseases, and aging.

As researchers continue to unravel the crosstalk between membrane biophysics and kinase activation, this work exemplifies how synergizing structural biology with cellular biochemistry can decode complex signaling circuits. Emerging methods to probe mTORC1 within endogenous lysosomal membranes in live cells, alongside kinetic analyses, will undoubtedly enrich the current model and may catalyze novel therapeutic strategies aimed at fine-tuning mTOR activity with exquisite spatiotemporal control.

Subject of Research: Structural Basis and Mechanism of mTORC1 Activation on the Lysosomal Membrane

Article Title: Structural basis for mTORC1 activation on the lysosomal membrane

Article References:
Cui, Z., Esposito, A., Napolitano, G. et al. Structural basis for mTORC1 activation on the lysosomal membrane. Nature (2025). https://doi.org/10.1038/s41586-025-09545-3

Image Credits: AI Generated

The researchers initiated their investigation by focusing on the recently identified interaction region between TTYH2 and unlipidated APOE. This foundational insight raised an important question: does TTYH2 interact similarly with APOE when it is incorporated into lipid-bound lipoprotein particles? To address this, the team successfully reconstituted disc-shaped lipoprotein particles, mimicking natural APOE-laden assemblies containing cholesterol and phospholipids, which were then introduced to either detergent-solubilized purified TTYH2 protein or cell-derived vesicles expressing TTYH2 in abundance. This dual approach enabled the exploration of TTYH2’s behavior in both isolated and membrane-embedded states.

High-resolution cryo-EM data revealed a heterogeneous distribution of particles when combined with detergent-solubilized TTYH2. Among these, discrete populations were identified corresponding to lipoproteins, TTYH2, and crucially, their complexes. The team reconstructed three distinct oval-shaped disc-like assemblies ranging in diameter from approximately 130 to 150 Å, dimensions consistent with APOE containing nanoparticles that incorporate lipids such as cholesterol and phospholipids. These structures exhibited a characteristic bimodal bilayer density corresponding precisely to the lipid head-group regions, confirming the fidelity of the reconstituted particles in replicating authentic lipoprotein discs.

Further refinement and classification of three-dimensional (3D) reconstructions provided compelling evidence of TTYH2-lipoprotein complexes. The cryo-EM maps, resolved to between 13 and 14 Å, revealed a clear density attributable to bound lipoprotein discs, mirroring the size and shape of free-standing lipoprotein particles. Notably, the binding interface was localized to the extracellular domain of TTYH2, overlapping with the previously characterized binding region for unlipidated APOE. Although current resolution limitations precluded atomic-level detail, this spatial proximity highlights a conserved binding motif that likely governs the affinity between TTYH2 and APOE irrespective of APOE’s lipidation status.

One of the most fascinating observations was the orientation of the lipoprotein discs relative to TTYH2. The portion engaged with the extracellular domain was found adjacent to the protein’s hydrophobic cavity — a structural feature known to harbor lipid-like density. This cavity had been unequivocally characterized in prior high-resolution structures of TTYH proteins, including the present study’s novel TTYH2 conformation. The spatial arrangement suggests a mechanism whereby TTYH2 directly interfaces with the lipid-rich face of the lipoprotein disc, positioning lipids in close apposition to the hydrophobic cavity and potentially facilitating lateral lipid transfer into the cellular membrane or endosomal vesicles.

Complementing the observations made with detergent-solubilized protein, a parallel structural analysis was performed on TTYH2 expressed within cell-derived vesicles. These in situ studies, yielding a reconstruction at 10.7 Å resolution, confirmed the preserved nature of the TTYH2-lipoprotein interaction within a native membrane environment. The extracellular domain of TTYH2 retained its lipoprotein-binding capacity, reinforcing the biological relevance of these interactions in physiological contexts. Importantly, the cytoplasmic domain, distinctly visible in these reconstructions, underscores the integral membrane protein architecture and suggests possible intracellular signaling or structural roles concomitant with lipid exchange.

The significance of these findings extends beyond structural novelty. TTYH2 appears to act as a molecular bridge, coupling extracellular APOE-containing lipoproteins with the cellular membrane to effectuate endosomal lipid transfer. This role resonates with longstanding hypotheses positing TTYH family proteins as facilitators of lipid trafficking and homeostasis. By providing a direct physical pathway for lipid molecules from lipoprotein particles into endosomal membranes, TTYH2 may modulate lipid composition in membranes, influence membrane fluidity, and impact cellular signaling cascades reliant on lipid mediators.

This novel structural insight also casts light on the physiological and pathological relevance of APOE isoforms. Given APOE’s central role in neurobiology, cardiovascular disease, and lipid metabolism, understanding how its lipoprotein forms interact with membrane proteins like TTYH2 could unlock new therapeutic avenues. For conditions such as Alzheimer’s disease, where APOE variants differ in lipid handling and neuronal impact, modulation of TTYH2-related lipid transfer pathways may offer a strategy to attenuate disease progression or restore lipid balance.

The study’s methodological rigor is notable, combining recombinant protein expression, biochemical reconstitution of lipoprotein discs, advanced cryo-EM imaging, and sophisticated 3D classification protocols. This integrative approach ensures that interpretations of the protein-lipoprotein complexes are grounded in structural authenticity and biological plausibility. The careful delineation of particle heterogeneity, coupled with targeted classification to isolate complexes, exemplifies the power of cryo-EM in resolving dynamic macromolecular assemblies.

Looking forward, the challenge remains to achieve higher resolution structures that can reveal atomic details of the TTYH2-APOE interface. Such advances would clarify specific amino acid interactions, the nature of lipid coordination within the hydrophobic cavity, and the dynamics of lipid transfer. Additionally, functional assays measuring lipid flux mediated by TTYH2 in living cells could complement structural data and validate the proposed lipid-transfer mechanism.

In conclusion, this pioneering work uncovers a sophisticated molecular interaction network wherein TTYH2 collaborates with APOE-containing lipoproteins to facilitate lipid transfer at the cellular interface. The detailed structural characterization of this complex opens new vistas into membrane biology and lipid metabolism, with far-reaching implications for understanding fundamental cellular processes and disease mechanisms involving lipid dysregulation.

Subject of Research: Interactions between TTYH2 and APOE facilitating endosomal lipid transfer.

Article Title: Interactions between TTYH2 and APOE facilitate endosomal lipid transfer.

Article References:
Sukalskaia, A., Karner, A., Pugnetti, A. et al. Interactions between TTYH2 and APOE facilitate endosomal lipid transfer. Nature (2025). https://doi.org/10.1038/s41586-025-09200-x

Image Credits: AI Generated